Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group-Reference-Cited by-同舟云学术

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

Published:2020-11 Issue:11 Volume:31 Page:1491-1505
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mosele F.,Remon J.,Mateo J.,Westphalen C.B.,Barlesi F.,Lolkema M.P.,Normanno N.,Scarpa A.,Robson M.,Meric-Bernstam F.,Wagle N.,Stenzinger A.,Bonastre J.,Bayle A.,Michiels S.,Bièche I.,Rouleau E.,Jezdic S.,Douillard J-Y.,Reis-Filho J.S.,Dienstmann R.,André F.

Funder

European Society for Medical Oncology

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference140 articles.

1. Is the $1000 genome as near as we think? A cost analysis of next-generation sequencing;van Nimwegen;Clin Chem,2016

2. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study;Marino;Eur J Hum Genet,2018

3. The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial;Pagès;Genet Med,2017

4. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing;Frampton;Nat Biotechnol,2013

5. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial;Tourneau;Lancet Oncol,2015

Cited by 795 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Assessing actionability and incidental findings of germline variants in two precision oncology trials;European Journal of Cancer;2024-10

3. The molecular tumor board as a step in cancer patient management: a southern Italian experience;Frontiers in Medicine;2024-09-11

4. Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer;Cancers;2024-09-09

5. Empowering effective biomarker-driven precision oncology: A call to action;European Journal of Cancer;2024-09